Contact Us | Find An Expert

Find an Expert
a

What to Expect With iStent inject® W

Take a Closer Look at the Procedure

Take Advantage of This Once-in-a-Lifetime Cataract Surgery and Glaucoma Therapy—All in One Procedure

If you have been managing your glaucoma with medication, and are now preparing for cataract surgery, iStent inject® W may be an ideal option for you. iStent inject® W is one of the smallest devices known to be implanted in the human body and it can have remarkable benefits for glaucoma patients with cataracts.

Ask Your Doctor About iStent inject® W Today!

If you have glaucoma and you’re planning on having cataract surgery, you may be a candidate for iStent inject® W. Talk to your doctor today to find out if iStent inject® W is right for you.

Find an Expert

What to Expect

Learn what to expect before, during, and after your iStent inject® W procedure.

Before the Procedure

You should continue to use any prescribed eye drops until your procedure, unless directed otherwise by your eye care professional. Before surgery, your eye surgeon will go over all the medications you’re currently taking. Be sure to bring a list of your current medications to your pre-operative appointment and be prepared to answer a few questions regarding your medical history.

During the Procedure

The cataract removal and iStent inject® W procedure are usually performed under local anesthesia. After your surgeon removes your cataracts, he or she will implant the iStent inject® W devices. Once implanted, you will not see or feel the devices.

After the Procedure

iStent inject® W is an outpatient procedure, which means you’ll be able to go home the same day following your surgery. After the procedure, you will likely receive antibiotic and anti-inflammatory eye drops to use. Your ophthalmologist will likely schedule an appointment to see you the day following the surgery.

Recovery time is usually quick, but your doctor may recommend that you take a few days off work and refrain from strenuous activities.

What are the Risk Factors?

The risks associated with performing cataract surgery with the iStent inject® W are similar to those related to performing cataract surgery alone. For more information regarding specific risks associated with your condition, please talk to your eye care professional.

Download Patient FAQs

Watch How the Procedure Works:

Hear from Others with Glaucoma

view patient stories

Are You Considering the iStent inject® W Procedure?

Find out if you are a candidate for iStent inject® W by speaking with an iStent inject® W physician in your area today.

Find a Physician

Stay Connected

Sign up to receive the latest information about glaucoma, new treatments, research findings and more!

Glaukos will use the information you provide on this form to be in touch with you.

Consent(Required)
This field is for validation purposes and should be left unchanged.

PM-US-0596

INDICATION FOR USE
The iStent inject® W Trabecular Micro-Bypass System Model G2-W is indicated for use in conjunction with cataract surgery for the reduction of intraocular pressure (IOP) in adult patients with mild-to-moderate primary open-angle glaucoma.

CONTRAINDICATIONS
The iStent inject® W is contraindicated in eyes with angle-closure glaucoma, traumatic, malignant, uveitic, or neovascular glaucoma, discernible congenital anomalies of the anterior chamber (AC) angle, retrobulbar tumor, thyroid eye disease, or Sturge-Weber Syndrome or any other type of condition that may cause elevated episcleral venous pressure.

WARNINGS
Gonioscopy should be performed prior to surgery to exclude congenital anomalies of the angle, PAS, rubeosis, or conditions that would prohibit adequate visualization of the angle that could lead to improper placement of the stent and pose a hazard.

MRI INFORMATION
The iStent inject® W is MR-Conditional, i.e., the device is safe for use in a specified MR environment under specified conditions; please see Directions for Use (DFU) label for details.

PRECAUTIONS
The surgeon should monitor the patient postoperatively for proper maintenance of intraocular pressure (IOP). The safety and effectiveness of the iStent inject® W have not been established as an alternative to the primary treatment of glaucoma with medications, in children, in eyes with significant prior trauma, abnormal anterior segment, chronic inflammation, prior glaucoma surgery (except SLT performed > 90 days preoperative), glaucoma associated with vascular disorders, pseudoexfoliative, pigmentary or other secondary open-angle glaucomas, pseudophakic eyes, phakic eyes without concomitant cataract surgery or with complicated cataract surgery, eyes with medicated intraocular pressure (IOP) > 24 mmHg or unmedicated intraocular pressure (IOP) < 21 mmHg or > 36 mmHg, or for implantation of more or less than two stents.

ADVERSE EVENTS
Common postoperative adverse events reported in the iStent inject® randomized pivotal trial included stent obstruction (6.2%), intraocular inflammation (5.7% for iStent inject® vs. 4.2% for cataract surgery only), secondary surgical intervention (5.4% vs. 5.0%) and BCVA loss ≥ 2 lines ≥ 3 months (2.6% vs. 4.2%).

CAUTION
Federal law restricts this device to sale by, or on the order of, a physician. Please see DFU for a complete list of contraindications, warnings, precautions, and adverse events.

Text Optimizer